Sustained release etodolac

Details Sustained release etodolac Sustained release etodolac

1988-11-07

1990-10-30

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

424469, 424470, 424488, A61K 922, A61K 926

Patent

active

049667688

ABSTRACT:
A sustained release dosage form of etodolac is provided which is a tablet having as essential components etodolac, hydroxyproplymethylcellulose, ethylcellulose and a release rate modifying agent such as dibasic sodium phosphate, the hydroxyproplymethylcellulose having a hydroxypropoxyl content of about 7.0% to 8.6% by weight.

REFERENCES:
patent: 3954959 (1976-05-01), Pedersen
patent: 4309404 (1982-01-01), DeNeale et al.
patent: 4309405 (1982-01-01), Guley et al.
patent: 4309406 (1982-01-01), Guley et al.
patent: 4369172 (1983-01-01), Schor et al.
patent: 4389393 (1983-06-01), Schor et al.
patent: 4657757 (1987-04-01), Hanna et al.

Affiliated with

Also associated with

Rating

Sustained release etodolac does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release etodolac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release etodolac will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-274360